Top 10 Neffy nasal spray company China Products Compare 2025

Are you curious about where the best neffy nasal sprays are made? With the growing demand for effective nasal delivery systems, understanding the top factories in China is more important than ever. By comparing these leading manufacturers, you can ensure that you’re choosing products that meet high standards of quality and safety. Imagine having the confidence that comes from knowing you’re using the best options available. So, let’s dive into this insightful comparison and discover which factories stand out in the world of neffy nasal sprays. Keep reading to find out more!

ARS Pharmaceuticals Announces Filings for Approval of neffy® in China …

Product Details: neffy® is an intranasal epinephrine product for emergency treatment of Type I allergic reactions, including anaphylaxis, in patients who weigh 30 kg or greater.

Technical Parameters:
– Dosage: 2 mg
– Shelf life: 30 months

Application Scenarios:
– Emergency treatment of severe allergic reactions
– Anaphylaxis due to food, medications, and insect bites

Pros:
– Needle-free administration
– Easy to dispose and portable

Cons:
– May cause throat irritation and nasal discomfort
– Requires immediate access to two nasal sprays at all times


ARS Pharmaceuticals Announces Filings for Approval of neffy® in China ...

ARS Pharmaceuticals Announces Filings for Approval of neffy® in China …

Product Details: neffy® (epinephrine nasal spray) 2 mg is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weigh 30 kg or greater.

Technical Parameters:
– Needle-free administration
– 30 month shelf life

Application Scenarios:
– Emergency treatment of severe allergic reactions
– Use in pediatric patients aged 6-17 with anaphylactic symptoms

Pros:
– Easy to use and dispose
– Rapid response with 100% effectiveness in clinical trials

Cons:
– Potential adverse reactions including throat irritation and headache
– Requires immediate access to two nasal sprays at all times


ARS Pharmaceuticals Announces Filings for Approval of neffy® in China ...

ARS Pharmaceuticals Announces Filings for Approval of neffy® in China …

Product Details: neffy® (epinephrine nasal spray) 2 mg is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weigh 30 kg or greater.

Technical Parameters:
– Needle-free administration
– 30 month shelf life

Application Scenarios:
– Emergency treatment of severe allergic reactions
– Anaphylaxis due to food, medications, and insect bites

Pros:
– Easy to use and dispose
– Rapid response with 100% effectiveness in clinical trials

Cons:
– Potential adverse reactions including throat irritation and headache
– Requires immediate access to two nasal sprays at all times


ARS Pharmaceuticals Announces Filings for Approval of neffy® in China ...

ARS Pharmaceuticals Announces Filings for Approval of – GlobeNewswire

Product Details: neffy (epinephrine nasal spray) 2 mg is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weigh 30 kg or greater.

Technical Parameters:
– Needle-free administration
– 30 month shelf life

Application Scenarios:
– Emergency treatment of severe allergic reactions
– Anaphylaxis due to food, medications, and insect bites

Pros:
– Easy to use and dispose
– Rapid response with 100% effectiveness in clinical trials

Cons:
– Potential adverse reactions including throat irritation and headache
– Requires immediate access to two nasal sprays at all times


ARS Pharmaceuticals Announces Filings for Approval of - GlobeNewswire

ARS Pharmaceuticals’ Licensing Partners File for Approval of neffy® 2 …

Product Details: neffy® is an intranasal epinephrine spray indicated for emergency treatment of Type I allergic reactions, including anaphylaxis, in patients weighing 30 kg or greater.

Technical Parameters:
– 2 mg dosage
– Temperature resistant up to 122°F (50°C) with a 30-month shelf life

Application Scenarios:
– Emergency treatment of severe allergic reactions
– Anaphylaxis due to food, medications, and insect bites

Pros:
– Needle-free and easy to use
– Demonstrated efficacy in clinical trials with a median symptom resolution time o…

Cons:
– Dependence on licensing partners for regulatory approvals
– Potential safety concerns impacting public perception


ARS Pharmaceuticals' Licensing Partners File for Approval of neffy® 2 ...

ARS inks ex-US licensing pact for Neffy worth up to $465M

Product Details: Neffy is an epinephrine nasal spray approved for the treatment of Type 1 allergic reactions, including anaphylaxis, in adults and children weighing at least 66 pounds.

Technical Parameters:
– Dosage: 2 mg
– Administration: Nasal spray

Application Scenarios:
– Emergency treatment for anaphylaxis
– Use by first responders and emergency medical units

Pros:
– Needle-free administration, making it easier to use in emergency situations
– Potential for widespread use among various groups, including airlines and emerge…

Cons:
– Regulatory restrictions may limit use by certain professionals
– Market competition with existing epinephrine autoinjectors


ARS inks ex-US licensing pact for Neffy worth up to $465M

ARS Pharmaceuticals files for approval of neffy in China … – Nasdaq

Product Details: neffy epinephrine nasal spray 2 mg

Technical Parameters:
– Approved for treatment of Type I Allergic Reactions
– Suitable for adults and children weighing greater than or equal to 30 kg

Application Scenarios:
– Emergency treatment for anaphylaxis
– Allergic reactions management

Pros:
– Quick administration via nasal spray
– Retains U.S. rights for neffy

Cons:
– Limited to specific weight range for use
– Approval pending in multiple countries


ARS Pharmaceuticals files for approval of neffy in China ... - Nasdaq

ARS Pharmaceuticals notes filings for neffy approval in China … – Nasdaq

Product Details: neffy epinephrine nasal spray 2 mg

Technical Parameters:
– Approved for Type I Allergic Reactions
– For adults and children weighing 30 kg or more

Application Scenarios:
– Emergency treatment for anaphylaxis
– Use in schools and public places

Pros:
– Quick administration via nasal spray
– Retains U.S. rights for ARS Pharmaceuticals

Cons:
– Limited to specific weight category
– Approval pending in some regions


ARS Pharmaceuticals notes filings for neffy approval in China ... - Nasdaq

ARS Pharmaceuticals Inc (SPRY) Expands Global Reach with Neffy Nasal …

Product Details: Neffy is an intranasal epinephrine product designed for emergency treatment of Type I allergic reactions, including anaphylaxis.

Technical Parameters:
– 2 mg epinephrine nasal spray
– Long shelf life of 30 months, withstands high temperatures up to 122°F (50°C)

Application Scenarios:
– Emergency treatment for severe allergic reactions
– Use in patients with needle phobia

Pros:
– Needle-free and easy to use
– Long shelf life and portable

Cons:
– Regulatory approval pending in key markets
– Potential safety concerns with epinephrine use

ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for …

Product Details: Neffy is an adrenaline nasal spray developed by ARS Pharmaceuticals, acquired by ALK for rights in Europe and Canada.

Technical Parameters:
– Needle-free delivery system
– Approved for treating anaphylaxis

Application Scenarios:
– Emergency treatment for severe allergic reactions
– Use in patients with needle aversion

Pros:
– User-friendly compared to traditional injectors
– Rapid response for anaphylaxis management

Cons:
– Changing clinical practices may take time
– Limited availability in some regions

Related Video

Comparison Table

Company Product Details Pros Cons Website
ARS Pharmaceuticals Announces Filings for Approval of neffy® in China … neffy® is an intranasal epinephrine product for emergency treatment of Type I allergic reactions, including anaphylaxis, in patients who weigh 30 kg o… – Needle-free administration – Easy to dispose and portable – May cause throat irritation and nasal discomfort – Requires immediate access to two nasal sprays at all times finance.yahoo.com
ARS Pharmaceuticals Announces Filings for Approval of neffy® in China … neffy® (epinephrine nasal spray) 2 mg is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric… – Easy to use and dispose – Rapid response with 100% effectiveness in clinical trials – Potential adverse reactions including throat irritation and headache – Requires immediate access to two nasal sprays at all times markets.businessinsider.com
ARS Pharmaceuticals Announces Filings for Approval of neffy® in China … neffy® (epinephrine nasal spray) 2 mg is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric… – Easy to use and dispose – Rapid response with 100% effectiveness in clinical trials – Potential adverse reactions including throat irritation and headache – Requires immediate access to two nasal sprays at all times www.biospace.com
ARS Pharmaceuticals Announces Filings for Approval of – GlobeNewswire neffy (epinephrine nasal spray) 2 mg is indicated for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric… – Easy to use and dispose – Rapid response with 100% effectiveness in clinical trials – Potential adverse reactions including throat irritation and headache – Requires immediate access to two nasal sprays at all times www.globenewswire.com
ARS Pharmaceuticals’ Licensing Partners File for Approval of neffy® 2 … neffy® is an intranasal epinephrine spray indicated for emergency treatment of Type I allergic reactions, including anaphylaxis, in patients weighing… – Needle-free and easy to use – Demonstrated efficacy in clinical trials with a median symptom resolution time o… – Dependence on licensing partners for regulatory approvals – Potential safety concerns impacting public perception www.nasdaq.com
ARS inks ex-US licensing pact for Neffy worth up to $465M Neffy is an epinephrine nasal spray approved for the treatment of Type 1 allergic reactions, including anaphylaxis, in adults and children weighing at… – Needle-free administration, making it easier to use in emergency situations – Potential for widespread use among various groups, including airlines… – Regulatory restrictions may limit use by certain professionals – Market competition with existing epinephrine autoinjectors www.fiercepharma.com
ARS Pharmaceuticals files for approval of neffy in China … – Nasdaq neffy epinephrine nasal spray 2 mg – Quick administration via nasal spray – Retains U.S. rights for neffy – Limited to specific weight range for use – Approval pending in multiple countries www.nasdaq.com
ARS Pharmaceuticals notes filings for neffy approval in China … – Nasdaq neffy epinephrine nasal spray 2 mg – Quick administration via nasal spray – Retains U.S. rights for ARS Pharmaceuticals – Limited to specific weight category – Approval pending in some regions www.nasdaq.com
ARS Pharmaceuticals Inc (SPRY) Expands Global Reach with Neffy Nasal … Neffy is an intranasal epinephrine product designed for emergency treatment of Type I allergic reactions, including anaphylaxis. – Needle-free and easy to use – Long shelf life and portable – Regulatory approval pending in key markets – Potential safety concerns with epinephrine use www.gurufocus.com
ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for … Neffy is an adrenaline nasal spray developed by ARS Pharmaceuticals, acquired by ALK for rights in Europe and Canada. – User-friendly compared to traditional injectors – Rapid response for anaphylaxis management – Changing clinical practices may take time – Limited availability in some regions www.pharmaceutical-technology.com

Frequently Asked Questions (FAQs)

What is Neffy nasal spray and how does it work?

Neffy nasal spray is a medication designed to deliver active ingredients through the nasal mucosa for quick absorption. It works by allowing the medication to bypass the digestive system, providing faster relief for conditions like allergies or nasal congestion.

Where are Neffy nasal spray products manufactured?

Neffy nasal spray products are manufactured in state-of-the-art facilities located in China. These factories adhere to strict quality control standards to ensure the safety and efficacy of the products.

Are the manufacturing facilities compliant with international standards?

Yes, the manufacturing facilities for Neffy nasal spray comply with international quality standards, including Good Manufacturing Practices (GMP). This ensures that every product is made with the highest quality and safety in mind.

How does Neffy ensure the quality of its nasal spray?

Neffy employs rigorous testing and quality assurance processes throughout the manufacturing stages. This includes raw material testing, in-process checks, and final product evaluations to ensure that every batch meets their high standards.

Can I trust the safety of Neffy nasal spray products?

Absolutely! Neffy nasal spray products undergo extensive testing and quality checks to ensure they are safe for use. The company is committed to transparency and provides information about their manufacturing processes to build trust with consumers.

Top 10 Neffy nasal spray company China Products Compare 2025

Contact [email protected] Whatsapp 86 15951276160

Send Your Inquiry Today